HIV – media

Could a Third Person Be Cured of HIV?

A U.K. man may be cured of HIV comes the announcement that a man in Germany may also be HIV-free thanks to a similar treatment
- Source: https://www.livescience.com/64938-hiv-cure-third-patient.html
- 636
- March 29, 2019
bone marrow genetic mutation. HIV
Plunging HIV Infections Linked to Increased U.S. PrEP use

Pre-exposure prophylaxis (PrEP) by U.S. residents against HIV infection has resulted in positive outcomes. Incidence of new HIV infections among those 13 years old and above fell during 2012 - 2016, and this plunge presented a statistically noteworthy association with an increase in drug prophylaxis among U.S. residents in the same duration.
- Source: MDEdge
- 704
- August 11, 2018
HIV Researches
Vaccine Against HIV

A research group from St.Petersburg Polytechnic University led by Professor Andrei Kozlov has published their study’s findings regarding HIV vaccine creation.
- Source: News Medical
- 685
- August 2, 2018
HIV Researches vaccines
Merck Presents 96-Week Doravirine HIV Data Three Months before PDUFA Date

96-week data on doravirine, Merck’s HIV drug, was posted by the drugmaker recently. Merck expects it to outrun drugs like Bristol-Myers Squibb’s Sustiva in combination regimens and antiretroviral drugs from AbbVie and Johnson & Johnson in viral suppression.
- Source: FierceBiotech
- 897
- July 27, 2018
HIV Merck Researches
Updated HIV Guidelines Recommend Immediate Treatment, Three-Drug Therapy

The 2018 Recommendations of the International Antiviral Society-USA (IAS-USA) suggests that early treatment in adult HIV patients brings about rapid and more definite decrease in viral load and better care of the patient.
- Source: MDEdge
- 783
- July 27, 2018
HIV Policies
Future HIV Drugs by Targeting the Capsid

Current HIV drugs usually act on enzymes needed by the virus throughout its survival. But no drug targets the outermost layer of the virus named the capsid, which protects the genetic material delivered into the host.
- Source: FiercePharma
- 865
- July 17, 2018
HIV Researches
Anti-HIV Drug Increases Life Expectancy

The research work under the lead investigator Amy Zheng of the Massachusetts General Hospital (MGH) Medical Practice Evaluation Center in Boston indicated that the Dolutegravir-based regimen would increase the life expectancy of HIV victims by 2.8 years and prevent 13,000 new HIV infections over 5 years. It was also revealed that this first-line treatment would be cost-effective in 2 years and cost-saving over 5 years.
- Source: medicalxpress
- 679
- June 8, 2018
HIV New Approvals
HIV Therapy – A Major Breakthrough

In 2015, it was reported that around 36.7 million people throughout the world were affected with AIDS, among which 1.1 million were stated as deceased. The majority of AIDS cases were recorded in various African countries followed by India.
- Source: Ddu
- 664
- May 30, 2018
HIV Researches Sanofi
Discovery of Muscle Builder Pill

An ultimate focus on a specific protein named myostatin has led to the discovery of a muscle building pill, that could easily reduce gym visits. Suppression of myostatin production could increase healthier muscle mass, which would act as markers in improving kidney and heart health.
- Source: Ddu
- 636
- May 28, 2018
HIV muscular dystrophy obesity Researches
Safer HIV drugs taken off the shelf by Gilead

It has been stated by the patients that Gilead concealed crucial information that the TDF drugs could trigger kidney and bone risks. A safer alternative in the form of TAF could have been incorporated while marketing Truvada and Atripla. The research into TAF was deliberately stopped and the drugs are not likely to be brought to the shelf in the near future.
- Source: drugdu
- 860
- May 11, 2018
Company Insights Gilead HIV

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.